Literature DB >> 14758303

Children with cancer, fever, and treatment-induced neutropenia: risk factors associated with illness requiring the administration of critical care therapies.

Daniel C West1, James P Marcin, Roland Mawis, Jingsong He, Audrey Nagle, Robert Dimand.   

Abstract

OBJECTIVES: To identify clinical and laboratory characteristics of pediatric patients with cancer, fever, and treatment-induced neutropenia, available at existing at initial presentation, that are independently associated with the development of illnesses requiring administration of critical care therapies.
METHODS: We retrospectively collected historical, clinical, and laboratory data on initial presentation for all pediatric (younger than 18 years) cancer patients admitted for fever and treatment-induced neutropenia at our institution over a 5-year period. The outcome variable was the need for administration of a critical care therapy within 24 hours of admission. A multivariable analysis was performed and internally validated using bootstrap analysis.
RESULTS: We identified 303 events in 143 patients, of which 36 (11.9%) received a critical care therapy. Higher temperature at presentation and capillary filling time (CFT) of >3 seconds retained significance in the multivariable analysis and were validated by the bootstrap analysis. The positive and negative predictive values of the presence of either temperature of > or =39.5 degrees C or CFT of >3 seconds were 35% and 91%, respectively.
CONCLUSIONS: Pediatric patients with cancer, fever, and treatment-induced neutropenia who present with higher fever or prolonged CFT are at increased risk of developing life-threatening illnesses requiring administration of critical care therapies, independent of hematologic factors, type of cancer, or other physiologic signs of sepsis.

Entities:  

Mesh:

Year:  2004        PMID: 14758303     DOI: 10.1097/01.pec.0000113875.10140.40

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

Review 1.  Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.

Authors:  Bob Phillips; Ros Wade; Lesley A Stewart; Alex J Sutton
Journal:  Eur J Cancer       Date:  2010-11       Impact factor: 9.162

2.  A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.

Authors:  Muayad Alali; Anoop Mayampurath; Yangyang Dai; Allison H Bartlett
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

3.  Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia.

Authors:  Gabrielle M Haeusler; Robert Phillips; Monica A Slavin; Franz E Babl; Richard De Abreu Lourenco; Francoise Mechinaud; Karin A Thursky
Journal:  EClinicalMedicine       Date:  2020-06-15

4.  Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.

Authors:  Gabrielle M Haeusler; Karin A Thursky; Monica A Slavin; Franz E Babl; Richard De Abreu Lourenco; Zoe Allaway; Francoise Mechinaud; Robert Phillips
Journal:  EClinicalMedicine       Date:  2020-01-07

Review 5.  Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol).

Authors:  Robert S Phillips; Alex J Sutton; Richard D Riley; Julia C Chisholm; Susan V Picton; Lesley A Stewart
Journal:  Syst Rev       Date:  2012-02-09

Review 6.  Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy.

Authors:  Federica Cennamo; Riccardo Masetti; Prisca Largo; Alberto Argentiero; Andrea Pession; Susanna Esposito
Journal:  Children (Basel)       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.